FDA creates safety council for postmarket review of vaccines, gene therapies

The FDA has established a CBER Safety Council within its Center for Biologics Evaluation and Research to strengthen oversight of vaccines, gene and cell therapies and blood products after they reach the market, the agency announced Nov. 19. The council took effect that day. The council will report directly to the center’s director and be […] The post FDA creates safety council for postmarket review of vaccines, gene therapies appeared first on Becker's Hospital Review | Healthcare New...

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.